In a landmark move, the U.S. Department of Justice initiated a formal rulemaking process in May 2024 to reschedule marijuana from a Schedule I to a Schedule III substance under the Controlled Substances Act. This proposal, influenced by recommendations from the Department of Health and Human Services, acknowledges marijuana’s accepted medical use and aims to reduce federal penalties associated with its use.
However, this shift has not been without controversy. A group of Republican senators, including Mitt Romney, expressed concerns that rescheduling could violate international treaties, urging the Drug Enforcement Administration to reconsider the move.
Legislatively, the Cannabis Administration and Opportunity Act, introduced in May 2024, seeks to decriminalize and deschedule cannabis federally. The bill also proposes reinvestment in communities adversely affected by past drug policies and expungement of certain cannabis-related offenses.
Dabbin-Dad Newsroom
Federal Developments: Rescheduling and Legislative Initiatives
If you liked this post, say thanks by sharing it
